SERIES A-7 COMMON STOCK PURCHASE WARRANT BAUDAX BIO, INC.Security Agreement • August 21st, 2023 • Baudax Bio, Inc. • Services-misc health & allied services, nec
THIS SERIES A-7 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that Nasdaq Shareholder Approval is obtained and deemed effective (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Baudax Bio, Inc., a Pennsylvania corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided, however, in the event that the Exercise Price is reduced pursuant to Section 2(b) hereunder during the Measurement Period(s), the number of the number of Warrant Shares issuable hereunder shall be increased such that the aggregate Exercise Price payable hereunder, after taking int
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 21st, 2023 • Baudax Bio, Inc. • Services-misc health & allied services, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 16, 2023, between Baudax Bio, Inc., a Pennsylvania corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
